New Flu Vaccine Uses mRNA to Target Four Viral Proteins that Change Little Between Strains

November 1, 2022

(Medical Xpress) – An international team of researchers has used mRNA technology to develop an influenza vaccine that targets four proteins that tend to change little across viral strains. In their paper published in Proceedings of the National Academy of Sciences, the group describes their approach to developing a new kind of flu vaccine and how well it has worked in test mice. (Read More)